Xilio Therapeutics Statistics
Total Valuation
XLO has a market cap or net worth of $45.45 million. The enterprise value is -$84.55 million.
Important Dates
The last earnings date was Monday, March 23, 2026, before market open.
| Earnings Date | Mar 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XLO has 5.78 million shares outstanding. The number of shares has increased by 118.70% in one year.
| Current Share Class | 5.25M |
| Shares Outstanding | 5.78M |
| Shares Change (YoY) | +118.70% |
| Shares Change (QoQ) | +246.46% |
| Owned by Insiders (%) | 10.16% |
| Owned by Institutions (%) | 19.63% |
| Float | 2.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.05 |
| Forward PS | 1.75 |
| PB Ratio | 0.73 |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.20.
| Current Ratio | 2.58 |
| Quick Ratio | 2.53 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -132.53% and return on invested capital (ROIC) is -77.21%.
| Return on Equity (ROE) | -132.53% |
| Return on Assets (ROA) | -23.24% |
| Return on Invested Capital (ROIC) | -77.21% |
| Return on Capital Employed (ROCE) | -42.66% |
| Weighted Average Cost of Capital (WACC) | 3.58% |
| Revenue Per Employee | $683,844 |
| Profits Per Employee | -$547,438 |
| Employee Count | 64 |
| Asset Turnover | 0.39 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.93% in the last 52 weeks. The beta is -0.02, so XLO's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -28.93% |
| 50-Day Moving Average | 8.01 |
| 200-Day Moving Average | 9.62 |
| Relative Strength Index (RSI) | 52.69 |
| Average Volume (20 Days) | 45,469 |
Short Selling Information
The latest short interest is 2.11 million, so 36.55% of the outstanding shares have been sold short.
| Short Interest | 2.11M |
| Short Previous Month | 2.16M |
| Short % of Shares Out | 36.55% |
| Short % of Float | 80.37% |
| Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, XLO had revenue of $43.77 million and -$35.04 million in losses. Loss per share was -$4.19.
| Revenue | 43.77M |
| Gross Profit | 43.77M |
| Operating Income | -41.98M |
| Pretax Income | -35.04M |
| Net Income | -35.04M |
| EBITDA | -40.44M |
| EBIT | -41.98M |
| Loss Per Share | -$4.19 |
Full Income StatementBalance Sheet
The company has $137.53 million in cash and $6.95 million in debt, with a net cash position of $130.58 million or $22.58 per share.
| Cash & Cash Equivalents | 137.53M |
| Total Debt | 6.95M |
| Net Cash | 130.58M |
| Net Cash Per Share | $22.58 |
| Equity (Book Value) | 35.27M |
| Book Value Per Share | 10.79 |
| Working Capital | 88.75M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.99 million and capital expenditures -$518,000, giving a free cash flow of -$5.51 million.
| Operating Cash Flow | -4.99M |
| Capital Expenditures | -518,000 |
| Depreciation & Amortization | 1.54M |
| Net Borrowing | n/a |
| Free Cash Flow | -5.51M |
| FCF Per Share | -$0.95 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -95.92% and -80.05%.
| Gross Margin | 100.00% |
| Operating Margin | -95.92% |
| Pretax Margin | -80.05% |
| Profit Margin | -80.05% |
| EBITDA Margin | -92.40% |
| EBIT Margin | -95.92% |
| FCF Margin | n/a |
Dividends & Yields
XLO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -118.70% |
| Shareholder Yield | -118.70% |
| Earnings Yield | -76.12% |
| FCF Yield | -11.97% |
Analyst Forecast
The average price target for XLO is $28.00, which is 256.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $28.00 |
| Price Target Difference | 256.23% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | -14.01% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 16, 2026. It was a reverse split with a ratio of 1:14.
| Last Split Date | Mar 16, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:14 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
